Europe Immunology Drugs Market Report Suite 2017 - ResearchAndMarkets.com

DUBLIN--()--The "Europe Market Report Suite for Immunology Drugs 2017 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Besides the typical market data found above you will be able to discover how these diseases have been trending over time, their epidemiology, drivers and limiters of these markets, Porter's Five Forces analysis, clinical trials, a pipeline of products coming out soon, mergers and acquisitions, company profiles and SWOT analyses.

Key Topics Covered:

Report Guidance

Market Definition

Research Methodology

Executive Summary

Disease Overview

Rheumatoid Arthritis

Crohn's Disease

Ankylosing Spondylitis

Psoriasis

Ulcerative Colitis

Product Assessment

Clinical Trials Overview

Pipeline Analysis

Promising new drugs for Ankylosing Spondylitis in the pipeline

Promising new drugs for Crohn's Disease in the pipeline

Promising new drugs for Psoriasis in the pipeline

Promising new drugs for Rheumatoid Arthritis in the pipeline

Key Marketed Products Portfolio

Orencia (abatacept)

Humira (adalimumab)

Cimzia (certolizumab)

Enbrel (etanercept)

Benepali (etanercept)

Simponi (golimumab)

Remicade (infliximab) + Remsima/Inflectra (infliximab)

Inflectra (infliximab)

Flixabi (infliximab)

Rituxan (rituximab)

Actemra/RoActemra (toclizumab)

XELJANZ (tofacitnib)

Kineret (anakinra)

Stelara (ustekinumab)

Entyvio (vedolizumab)

Tysabri (natalizumab)

Cosentyx (secukinumab)

Taltz (ixekizumab)

Drug Cost Analysis

Europe Immunology Market Overview

Introduction

Currency Exchange Rate

Europe Immunology Market - By Diseases

Market Overview

Rheumatoid Arthritis

Crohn's Disease

Ankylosing Spondylitis

Psoriasis

Ulcerative Colitis

Europe Immunology Market - By Treatments

Market Overview

Biologics (Biologic DMARDS)

Non-biologics (corticosteroids, NSAIDs, tDMARDS & other non-biologic)

Europe Immunology Biologics Segment Analysis - By Drugs

Rheumatoid Arthritis Drugs

Crohn's Disease Drugs

Ankylosing Spondylitis Drugs

Psoriasis Drugs

Ulcerative Colitis Drugs

Europe Immunology Biologics Segment Analysis - By Mechanism Of Action (MOA)

TNF

JFK

Others

Country Profiles

United Kingdom

France

Germany

Italy

Spain

Rest of Europe

Competitive Landscape

Mergers & Acquisitions

Collaborations & Agreements

Market Shares & Competitive Analysis - by key players

Company Profiles

  • AbbVie Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceuticals
  • UCB S.A.

For more information about this report visit https://www.researchandmarkets.com/research/hwsz5v/europe_immunology?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900